Johnson & Johnson vaccine should be paused in U.S. after 'extremely rare' blood clots, FDA and CDC say

Some 6.8 million have received the vaccine in the United States. Of these six have experienced the clot, the FDA and CDC said. Federal health agencies on Tuesday recommended pausing the use of the Johnson & Johnson vaccine after a small number of people experienced “a rare and severe type of blood …

Read more

Show More

Related Articles

Back to top button